Senseonics, a company based in Germantown, Maryland, won FDA approval for its Eversense continuous glucose monitoring system. This is the first implantable, long term blood sugar monitor that can be used for up to three months at a time.
The technology relies on a small device that’s implanted under the skin of the upper arm. A transmitter i (Read more...)